Download Asadullah K., Sterry W., Volk ... new approach. Pharmacol Rev. 55:241-69. DAFTAR PUSTAKA

DAFTAR PUSTAKA
Asadullah K., Sterry W., Volk H. D. 2003. Interleukin-10 therapy – review of a
new
approach. Pharmacol Rev. 55:241-69.
Balkwill F., Mantovani A. 2001. Inflammation and cancer: back to Virchow?.
Lancet.357: 539-45.
Barrat F. J., et al. 2002. In vitro generation of interleukin 10-producing regulatory
CD4+ T cells is induced by immunosuppressive drugs and inhibited by T
helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195, 603–
616.
Blomhoff R., & Blomhoff H. K. 2006. Overview of retinoid metabolism and
function. J. Neurobiol. 66, 606–630.
Bourreille A,. Segain J. P., Raingeard de la Bletiere D., Siavoshian S., Valette
G.,Galmiche J. P., and Blottiere H. M. 1999. Lack of IL-10 regulation of
antigen presentation-associated molecules expressed on colonic epithelial
cells. Eur J Clin Investig. 29: 48–55.
Boonstra A., et al. 2006. Macrophages and myeloid DC, but not plasmacytoid
DC, produce IL-10 in response to MyD88- and TRIF- dependent TLR
signals, and TLR-independent signals. J. Immunol. 177,7551–7558.
Carson W.E., Lindemann M. J., Baiocchi R., Linett M., Tan J. C., Chou C. C.,
Narula S., and Caligiuri M. A. 1995. The functional characterization of
interleukin-10 receptor expression on human natural killer cells. Blood. 85:
3577–85.
Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. 2009. Cancer-related
inflammation, the seventh hallmark of cancer: links to genetci instability.
Carcinogenesis 30: 1073-1081.
Dawson H. D. et al. 2006. Direct and indirect effects of retinoic acid on human
Th2 cytokine and chemokine expression by human T lymphocytes. BMC
Immunol. 7, 27.
Dillon S., et al. 2004. A Toll‑like receptor 2 ligand stimulates Th2 responses in
vivo,
via
induction
of
extracellular
42
signal‑regulated
kinase
43
mitogen‑activated protein kinase and c‑Fos in dendritic cells. J. Immunol.
172, 4733–4743.
Drake R.L., Vogi W., Mitchell A.W.M. 2007. Grays Anatomy. 2nd ed. China:
Elsevier Churchill Livingstone p. 279.
Eaden J. A., Abrams K. R., Mayberry J. F. 2001. The risk of colorectal cancer in
ulcerative colitis: a meta-analysis. Gut 48: 526-535.
Franke A., et al. 2008. Sequence variants in IL10, ARPC2 and multiple other loci
contribute to ulcerative colitis susceptibility. Nature Genet. 40, 1319–1323.
Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., and O'Garra A. 1991.
IL-10
inhibits
cytokine
production
by activated
macrophages.
J
Immunol.147: 3815-22.
Gartner L.P., Hiatt J.L. 2007. Color Textbook of Histology. 3th ed. Philadelphia :
W.B Saunders Company. 398-409.
Gillen C.D., et al. 1994. Ulcerative colitis and Crohn’s disease: a comparison of
the colorectal cancer risk in extensive colitis. Gut, 35, 1590-1592.
Gommeaux J., Cano C., Garcia S., Gironella M., Pieri S., Culcasi M. et al. 2007.
Colitis and colitis-assosiated cancer are exacerbated in mice deficient for
tumor protein 53-induced nuclear protein 1. Mol. Cell. Biol. 27(6): 2215-28.
Hana Ratnawati, Khie Khiong, Sylvia Soeng, Sri Utami Sugeng, Evan Kristiono,
Shella Hudaya. 2008. Pengaruh ekstrak Buah Merah (Pandanus conoideus
Lam.) terhadap berat limpa, jumlah dan proliferasi limfosit pada mencit
jantan galur Swiss-webster yang diinokulasi Listeria monocytogenes.
Disampaikan dalam KONAS XII dan PIN PAAI (Perhimpunan Ahli
Anatomi Indonesia) Jakarta, 20-21 Juni.
Hanahan D., Weinberg R.A. 2000. The Hallmarks of cancer. Cell. 100: 57-70.
Hawrylowicz C. M., O’Garra, A. 2005. Potential role of interleukin‑10‑secreting
regulatory T cells in allergy and asthma. Nature Rev. Immunol. 5, 271–283.
I Made Budi. 2005. Seri Agrisehat Buah Merah. Jakarta: Penebar Swadaya. 17-23.
Iwasaki A., Kelsall B. L. 2001. Unique functions of CD11b+, CD8α+, and
double-negative Peyer’s patch dendritic cells. J. Immunol. 166, 4884–4890.
Iwasaki A. 2007. Mucosal dendritic cells. Annu. Rev.Immunol. 25: 381–418 .
44
Iwasaki A., Kelsall B. L. 2001. Unique functions of CD11b+, CD8α+, and
double-negative Peyer’s patch dendritic cells. J. Immunol. 166: 4884–90.
Izcue A., Coombes J. L., Powrie F. 2009. Regulatory lymphocytes and intestinal
inflammation. Annu. Rev. Immunol. 27, 313–338.
Jemal A., Siegel R., Ward E., Murray T., Xu J., Thu M.J. 2007 Cancer statistics,
CA cancer J Clin. 57:43-66
Kang S. S., Allen P. M. 2005. Priming in the presence of IL-10 results in direct
enhancement of CD8+ T cell primary responses and inhibition of secondary
responses J. Immunol. 174: 5382-9.
Karin M., 2008. The NF-κB kinase-a bridge between inflammation and cancer.
Cell research. 18:334-342.
Karin M., Greten F.R. 2005. NF-κB linking inflammation and immunity to cancer
development and progression. Nature Rev Immunol. 5: 749-759.
Kaiser F. et al. 2009. TPL‑2 negatively regulates interferon‑β production in
macrophages and myeloid dendritic cells. J. Exp. Med. 206, 1863–1871.
Kemas Ali Hanafiah. 2005. Rancangan Percobaan Apilkatif: aplikasi kondisional
bidang pertanaman, perternakan, perikatan, industri, dan hayati. Jakarta: PT
Raja Grafindo Persada. p10-12.
Kim S. et al. 2009. Carcinoma-produced factors activate myeloid cells trough
TLR2 to stimulate metatasis. Nature 457, 102-106.
Kobayashi M., et al. 2003. Toll-like receptor-dependent production of IL-12p40
causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J.
Clin. Invest. 111: 1297–308.
Kucharzik T., Lugering N., Pauels H. G., Domschke W., and Stoll R. 1995. IL-4,
IL-10 and IL-13 down-regulate monocyte-chemoat-tracting protein-1
(MCP-1) production in activated intestinal epithelial cells. Clin. Exp.
Immunol. 111: 152-157.
Kuhn R,, Lohler J,, Rennick D,, Rajewsky K,, and Muller W. 1993. Interleukin10-deficient mice develop chronic enterocolitis. Cell. 75: 263-74.
Kundu J. K., Surh Y. J. 2008. Inflammation: gearing the journey to cancer. Mutat
Res 659: 15-30.
45
Lewin K. J., Riddell R. H., and Weinstein W. M. 1992. Inflammatory bowel
diseases. In: Gastrointestinal Pathology and Its Clinical Implications, KJ
Lewin, RH Riddell, and WM Weinstein (eds).Igaku-Shoin, New York, pp.
812-989.
Lin W. W., Karin M. 2007. A cytokine-mediated link between innate immunity,
inflammation and cancer. JCI. 117(5):1175-83.
Mathurin P., Xiong S., Kharbanda K. K., Veal N., Miyahara T., Motomura K.,
Ripper R. A., Bachem M. G., and Tsukamoto H. 2002. IL-10 receptor and
coreceptor expression in quiescent and activated stellate cells. Am J Physiol
Gastrointest Liver Physiol. 282: 981-90.
Mantovani A.2009. Cancer-related inflammation: the seventh hallmark of cancer.
American Society of Clinical Oncology. 723-726.
Maynard C. L. et al. 2007. Regulatory T cells expressing interleukin 10 develop
from Foxp3+ and Foxp3– precursor cells in the absence of interleukin 10.
Nature Immunol. 8, 931–941.
Maynard C. L., Weaver C. T. 2008. Diversity in the contribution of interleukin‑10
to T‑cell‑mediated immune regulation. Immunol. Rev. 226, 219–233 .
Medzhitov R. 2007. Recognition of microorganisms and activation of the immune
response. Nature 449, 819–826.
Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature, 454,
428-435.
Moore K. W., de Waal Malefyt R., Coffman R. L., O’Garra A. 2001. Interleukin10 and the interleukin-10 receptor Annu. Rev. Immunol. 19: 683-765.
Mora J. R., et al. 2006. Generation of gut-homing IgAsecreting B cells by
intestinal dendritic cells. Science 314, 1157–1160.
Murray
P.
J.
2006.
Understanding
and
exploiting
the
endogenous
interleukin‑10/STAT3‑mediated antiinflammatory response. Curr. Opin.
Pharmacol. 6, 379–386.
Mucida D., et al. 2007. Reciprocal TH17 and regulatory T cell differentiation
mediated by retinoic acid. Science 317, 256–260.
46
O’Garra A., Barrat F. J., Castro A. G., Vicari A., Hawrylowicz C. 2008. Strategies
for use of IL‑10 or its antagonists in human disease. Immunol. Rev.
223,114–131 .
O’Garra A. & Vieira P. 2004. Regulatory T cells and mechanisms of immune
system control. Nature Med. 10, 801–805.
Riddell R. H. 1995. Pathology of idiopathic inflammatory bowel disease. In:
Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds). Williams &
Wilkins, Baltimore, Maryland, pp. 517-552.
Roncarolo M. G. et al. 2006. Interleukin‑10‑secreting type 1 regulatory T cells in
rodents and humans. Immunol. Rev. 212, 28–50.
Rosenberg D., Giardina C., Tanaka T. 2009. Mouse models for study of colon
carcinogenesis. Carcinogenesis. 30(2): 183-96.
Saraiva M., et al. 2009. Interleukin-10 production by Th1 cells requires
interleukin-12-induced STAT4 transcription factor and ERK MAP kinase
activation by high antigen dose. Immunity 31, 209–219.
Saraiva M. & O’Garra A. 2010. The Regulation of IL-10 production by immune
cells. Nature Med. 10, 170-181.
Smith P. D., Ochsenbauer-Jambor, C. & Smythies, L. E. 2005. Intestinal
macrophages: unique effector cells of the innate immune system. Immunol.
Rev. 206: 149–59.
Smythies L. E., et al. 2005. Human intestinal macrophages display profound
inflammatory anergy despite avid phagocytic and bacteriocidal activity. J.
Clin. Invest. 115: 66–75.
Sun C. M., et al. 2007. Small intestine lamina propria dendritic cells promote de
novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204:
1775–85.
Suzuki R., Kohno H., Suige S., Nakagama H., Tanaka T. 2006. Strain differences
in the susceptibility to azoxymethane and dextran sodium sulfate-induced
colon carcinogenesis in mice. Carcinogenesis. 27(1):162-9
Stephensen C. B. 2001. Vitamin A, infection, and immune function. Annu. Rev.
Nutr. 21: 167–192.
47
Tanaka T., et al. 2003. A novel inflammation-related mouse colon carcinogenesis
model induced by azoxymethane and dextran sodium sulfate. Cancer Sci.
94:965–73.
Tanaka T., Oyama T., Yasui Y. 2008. Dietary supplements and colorectal cancer.
Curr Nuetraceut Res. 6:165-88.
Tanaka T. 2009. Colorectal Carcinogenesis : Review Of Human And
Experimental Animal Studies. Journal of Carcinogenesis; 8 : 5.
Vakkila J., Lotze M.T. 2004. Inflammation and necrosis promote tumour growth.
Nature Rev Immunol. 4: 641-648.
de Waal Malefyt R., Haanen J., Spits H., Roncarolo M. G., te Velde A., Figdor C.,
et al. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigenspecific human T cell proliferation by diminishing the antigen-presenting
capacity
of
monocytes
via
downregulation
of
class
II
major
histocompatibility complex expression. J Exp Med.174: 915-24.
Wang, Jingsong., Fathman J. W., Vilarino G. L., Scimnone L., Andrian U. H.
2006. Transcription Factor T-Bet Regulates Inflamatory Arthritis Through
Its Function In Dendritic Cell. J.Clin invest 116:414-421.
Yang H., Rotter J. I. 1995. Genetic aspects of idiopathic inflammatory bowel
disease. In: Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds).
Williams & Wilkins, Baltimore, Maryland, pp. 301-331.
Yoshimura A. 2006. Signal transduction of inflammatory cytokines and tumor
development. Cancer Sci. 97(6): 439-47.
Zhu J., et al. 2004. Conditional deletion of Gata3 shows its essential function in
TH1–TH2 responses. Nature Immunol. 5, 1157–1165.